platinum has been researched along with Kaposi Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behera, D; Lawania, S; Sharma, S; Singh, N | 1 |
| Fraval, HN; Rawlings, CJ; Roberts, JJ | 1 |
2 other study(ies) available for platinum and Kaposi Disease
| Article | Year |
|---|---|
Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis; Treatment Outcome; Xeroderma Pigmentosum | 2017 |
Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus.
Topics: Cell Line; Cell Survival; DNA; DNA Repair; Dose-Response Relationship, Drug; Endonucleases; Micrococcus; Phenotype; Platinum; Xeroderma Pigmentosum | 1978 |